Wells Fargo Portfolio holdings
Wells Fargo & Company, founded in 1852 by Henry Wells and William Fargo, is a major American financial institution headquartered in San Francisco, California, known for its extensive retail banking network and historical roots in the American West. Offering a wide range of services—including consumer banking, mortgages, wealth management, and commercial finance—it manages trillions in assets and serves millions of customers through thousands of branches and ATMs across the U.S. Despite its prominence, Wells Fargo faced significant scrutiny following a 2016 scandal involving millions of unauthorized accounts, leading to leadership changes and regulatory penalties, though it has since focused on rebuilding trust and enhancing digital banking capabilities. With a legacy tied to stagecoaches and a modern focus on diversified financial services, Wells Fargo remains a key player in the U.S. banking sector.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$876M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$854M |
| 3 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$377M |
| 4 |
Amazon
AMZN
|
+$362M |
| 5 |
NVIDIA
NVDA
|
+$332M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$721M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$567M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$527M |
| 4 |
Norfolk Southern
NSC
|
+$498M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$481M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.85% |
| 2 | Financials | 7.71% |
| 3 | Healthcare | 7.11% |
| 4 | Industrials | 6.24% |
| 5 | Consumer Discretionary | 5.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
Celldex Therapeutics
CLDX
$3.34B
| $762K | ﹤0.01% |
22,411
-325
| -1% | -$12.4K |
|
3577
Koppers
KOP
$949M
| $760K | ﹤0.01% |
20,812
-2,062
| -9% | -$77K |
|
3578
Artivion
AORT
$1.28B
| $759K | ﹤0.01% |
28,524
+4,822
| +20% | +$125K |
|
3579
Neumora Therapeutics
NMRA
$298M
| $759K | ﹤0.01% |
57,457
-1,023
| -2% | -$11.9K |
|
3580
Recursion Pharmaceuticals
RXRX
$1.75B
| $758K | ﹤0.01% |
115,017
+37,802
| +49% | +$271K |
|
|
SEZL
3581
Sezzle
SEZL
$4.01B
| $757K | ﹤0.01% |
26,640
+21,924
| +465% | +$426K |
|
|
LIF
3582
Life360
LIF
$5.15B
| $757K | ﹤0.01% |
19,243
+19,223
| +96,115% | +$673K |
|
3583
GoodRx Holdings
GDRX
$1.29B
| $756K | ﹤0.01% |
108,960
+71,312
| +189% | +$560K |
|
3584
G-III Apparel Group
GIII
$1.48B
| $756K | ﹤0.01% |
24,756
+830
| +3% | +$22.7K |
|
3585
Appian
APPN
$2.54B
| $753K | ﹤0.01% |
22,045
-2,058
| -9% | -$66.6K |
|
3586
Kyverna Therapeutics
KYTX
$485M
| $752K | ﹤0.01% |
153,787
+41,078
| +36% | +$317K |
|
3587
Quanex
NX
$970M
| $751K | ﹤0.01% |
27,063
-73
| -0.3% | -$2.08K |
|
3588
Tennant Co
TNC
$1.21B
| $751K | ﹤0.01% |
7,819
+400
| +5% | +$39K |
|
3589
Cannae Holdings
CNNE
$640M
| $750K | ﹤0.01% |
39,361
+1,259
| +3% | +$24.2K |
|
3590
Columbus McKinnon
CMCO
$557M
| $750K | ﹤0.01% |
20,833
-1,956
| -9% | -$66.4K |
|
3591
Invesco Golden Dragon China ETF
PGJ
$99.7M
| $750K | ﹤0.01% |
26,591
+490
| +2% | +$11K |
|
|
SAFE
3592
Safehold
SAFE
$1.1B
| $748K | ﹤0.01% |
28,535
+404
| +1% | +$9.53K |
|
|
CSR
3593
Centerspace
CSR
$933M
| $745K | ﹤0.01% |
10,568
+558
| +6% | +$40.1K |
|
3594
SLM Corp
SLM
$5.14B
| $744K | ﹤0.01% |
32,550
-1,819
| -5% | -$39.2K |
|
3595
State Street US Sector Rotation ETF
XLSR
$1.05B
| $743K | ﹤0.01% |
14,338
+4,976
| +53% | +$251K |
|
3596
Anavex Life Sciences
AVXL
$312M
| $743K | ﹤0.01% |
130,794
+46,431
| +55% | +$268K |
|
3597
TriCo Bancshares
TCBK
$1.81B
| $741K | ﹤0.01% |
17,382
+1,275
| +8% | +$55K |
|
|
EFT
3598
Eaton Vance Floating-Rate Income Trust
EFT
$289M
| $739K | ﹤0.01% |
57,361
+2,702
| +5% | +$35.6K |
|
|
SRCL
3599
DELISTED
Stericycle Inc
SRCL
| $738K | ﹤0.01% |
12,095
-2,721
| -18% | -$162K |
|
3600
Payoneer
PAYO
$2.41B
| $737K | ﹤0.01% |
97,916
-141,486
| -59% | -$919K |
|
Similar funds
Wells Fargo's Q3 2024 Portfolio in Review
As of Q3 2024, Wells Fargo held 7,190 positions worth $442B, up 7.1% from $412B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Wells Fargo's Q3 2024 filing shows 420 new, 2,836 increased, 2,619 reduced and 375 closed positions. Its largest new stake was Astoria US Quality Kings ETF: 614,874 shares worth $18.9M. The largest sale was iShares Core US Aggregate Bond ETF, an estimated $721M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Wells Fargo's largest Q3 2024 buy was Astoria US Quality Kings ETF: 614,874 shares worth $18.9M.
- Wells Fargo added most to Broadcom in Q3 2024, an estimated $876M increase.
- Wells Fargo's biggest Q3 2024 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $721M.
- Wells Fargo fully exited FT Vest US Equity Buffer ETF December in Q3 2024, selling an estimated $41.8M.
- Wells Fargo's ten largest holdings make up 18% of its $442B portfolio in Q3 2024.
- Wells Fargo opened 420 new positions and closed 375 in Q3 2024.
- Wells Fargo's portfolio value rose 7.1% quarter-over-quarter to $442B.
Based on Wells Fargo's 13F filing for Q3 2024, filed 13 Nov 2024.